Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: 10 vs 14 Days
NCT05049902Phase 4Completed
- Sponsor
- Shandong University
- Start
- Sep 2021
- Primary completion
- May 2023
- Modality
- Polymer-based Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan, amoxicillin, clarithromycin, tetracycline, metronidazole in Helicobacter pylori infection, sponsored by Shandong University. Started Sep 2021; status: completed.
02
Drugs
vonoprazanamoxicillinclarithromycintetracyclinemetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05049902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05049902.